Menu
Back to User profile » Ms Tatiana Dilla
Papers published by Ms Tatiana Dilla:
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W
ClinicoEconomics and Outcomes Research 2019, 11:395-403
Published Date: 6 June 2019
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S
ClinicoEconomics and Outcomes Research 2018, 10:747-759
Published Date: 12 November 2018
Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population
Dilla T, Lizan L, Paz S, Garrido P, Avendaño C, Cruz-Hernández JJ, Espinosa J, Sacristán JA
Patient Preference and Adherence 2016, 10:1-7
Published Date: 18 December 2015
Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
Dilla T, Ciudad A, Álvarez M
Patient Preference and Adherence 2013, 7:275-284
Published Date: 4 April 2013
Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics
Bernardo M, San L, Olivares JM, Dilla T, Polavieja P, Gilaberte I, Álvarez M, Ciudad A
Patient Preference and Adherence 2011, 5:601-610
Published Date: 7 December 2011